ATE117369T1 - Rekombinantes virus der marekschen krankheit und vakzin. - Google Patents
Rekombinantes virus der marekschen krankheit und vakzin.Info
- Publication number
- ATE117369T1 ATE117369T1 AT89302485T AT89302485T ATE117369T1 AT E117369 T1 ATE117369 T1 AT E117369T1 AT 89302485 T AT89302485 T AT 89302485T AT 89302485 T AT89302485 T AT 89302485T AT E117369 T1 ATE117369 T1 AT E117369T1
- Authority
- AT
- Austria
- Prior art keywords
- disease virus
- marek
- recombinant
- virus
- present
- Prior art date
Links
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000271566 Aves Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6697388 | 1988-03-20 | ||
| JP63230851A JP2779447B2 (ja) | 1988-03-20 | 1988-09-14 | 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE117369T1 true ATE117369T1 (de) | 1995-02-15 |
Family
ID=26408175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89302485T ATE117369T1 (de) | 1988-03-20 | 1989-03-14 | Rekombinantes virus der marekschen krankheit und vakzin. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5650153A (de) |
| EP (1) | EP0334530B1 (de) |
| JP (1) | JP2779447B2 (de) |
| KR (1) | KR920000116B1 (de) |
| AT (1) | ATE117369T1 (de) |
| AU (1) | AU619812B2 (de) |
| CA (1) | CA1340243C (de) |
| DE (1) | DE68920610T2 (de) |
| ES (1) | ES2066842T3 (de) |
| HU (1) | HUT52555A (de) |
| MY (1) | MY103854A (de) |
| NZ (1) | NZ228409A (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2583115B2 (ja) * | 1988-09-10 | 1997-02-19 | 財団法人化学及血清療法研究所 | 組換えマレック病ウイルスおよびその製法 |
| GB8821441D0 (en) * | 1988-09-13 | 1988-10-12 | Animal Health Inst | Viral vectors |
| DE69020848D1 (de) * | 1989-10-20 | 1995-08-17 | Akzo Nobel Nv | Impfstoff gegen IBV. |
| ES2070997T3 (es) * | 1989-12-04 | 1995-06-16 | Akzo Nobel Nv | Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos. |
| EP0473210B1 (de) * | 1990-07-30 | 1994-04-13 | Akzo Nobel N.V. | Rekombinantes Mareks-Krankheitsvirus |
| US5231023A (en) * | 1990-07-30 | 1993-07-27 | Akzo N.V. | Recombinant Marek's disease virus |
| FR2666589B1 (fr) * | 1990-09-07 | 1994-08-05 | Rhone Merieux | Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede. |
| US5690939A (en) * | 1991-05-14 | 1997-11-25 | Akzo Nobel N.V. | Recombinant vaccine against marek's disease |
| ZA923041B (en) * | 1991-05-14 | 1993-04-28 | Akzo Nv | Recombinant vaccine against marek's disease |
| AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
| IL104382A0 (en) * | 1992-01-17 | 1993-05-13 | Solvay Animal Health Inc | Vaccine containing acemannan as an adjuvant |
| CA2158935A1 (en) * | 1993-10-12 | 1995-04-20 | Chiron Viagene, Inc. | Methods for preserving recombinant viruses |
| JPH09508005A (ja) * | 1994-01-11 | 1997-08-19 | コーネル リサーチ ファンデーション インコーポレイテッド | 潜伏と腫瘍細胞発生の阻害によるマレク病の抑制 |
| JPH1084969A (ja) * | 1996-09-19 | 1998-04-07 | Chemo Sero Therapeut Res Inst | ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法 |
| GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
| EP1038952A3 (de) * | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Verfahren zur Herstellung von Mareks Disease Virus (MDV) unter Verwendung von kontinuierlichen Vogelzellinien |
| PT2785374T (pt) | 2011-11-30 | 2019-05-09 | Merial Ltd | Vectores recombinantes do herpesvírus 3 dos galídeos (mdv serotipo 2) expressando antigénios de agentes patogénicos aviários e suas utilizações |
| US9114108B2 (en) | 2011-11-30 | 2015-08-25 | Merial, Inc. | Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof |
| CN117357642A (zh) | 2016-12-14 | 2024-01-09 | 勃林格殷格翰动物保健美国公司 | 表达禽病原体的多种抗原的重组hvt载体及其用途 |
| AU2020347180A1 (en) | 2019-09-11 | 2022-03-24 | Zoetis Services Llc | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof |
| MA58717A1 (fr) | 2020-06-17 | 2023-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations |
| CN119842637A (zh) * | 2025-03-18 | 2025-04-18 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 表达IBDV VP2和FAdV-4 Fiber2基因的重组马立克氏病病毒及其构建方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH666035A5 (de) * | 1984-12-24 | 1988-06-30 | Sandoz Ag | 8-alpha-acylaminoergolene. |
| EP0231209B1 (de) * | 1985-07-29 | 1991-02-06 | The Upjohn Company | Virus-impfstoff |
| EP0256092B1 (de) * | 1986-01-27 | 1998-04-08 | Syntro Corporation | Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten |
| WO1988007088A1 (en) * | 1987-03-19 | 1988-09-22 | Synergen, Inc. | Viral vector system for the introduction of foreign dna expression products into gallinaceous birds |
| EP0284416B1 (de) * | 1987-03-27 | 1995-02-22 | Nippon Zeon Co., Ltd. | Rekombinantes Avipoxvirus |
| FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
-
1988
- 1988-09-14 JP JP63230851A patent/JP2779447B2/ja not_active Expired - Fee Related
-
1989
- 1989-03-14 EP EP89302485A patent/EP0334530B1/de not_active Expired - Lifetime
- 1989-03-14 AT AT89302485T patent/ATE117369T1/de not_active IP Right Cessation
- 1989-03-14 ES ES89302485T patent/ES2066842T3/es not_active Expired - Lifetime
- 1989-03-14 DE DE68920610T patent/DE68920610T2/de not_active Expired - Fee Related
- 1989-03-15 CA CA000593826A patent/CA1340243C/en not_active Expired - Fee Related
- 1989-03-17 AU AU31428/89A patent/AU619812B2/en not_active Ceased
- 1989-03-18 MY MYPI89000341A patent/MY103854A/en unknown
- 1989-03-20 KR KR1019890003474A patent/KR920000116B1/ko not_active Expired
- 1989-03-20 HU HU891319A patent/HUT52555A/hu unknown
- 1989-03-20 NZ NZ228409A patent/NZ228409A/xx unknown
-
1994
- 1994-08-24 US US08/293,337 patent/US5650153A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA1340243C (en) | 1998-12-15 |
| US5650153A (en) | 1997-07-22 |
| NZ228409A (en) | 1990-09-26 |
| KR890014740A (ko) | 1989-10-25 |
| AU3142889A (en) | 1989-09-21 |
| DE68920610T2 (de) | 1995-08-31 |
| EP0334530A1 (de) | 1989-09-27 |
| JP2779447B2 (ja) | 1998-07-23 |
| MY103854A (en) | 1993-09-30 |
| ES2066842T3 (es) | 1995-03-16 |
| EP0334530B1 (de) | 1995-01-18 |
| HUT52555A (en) | 1990-07-28 |
| AU619812B2 (en) | 1992-02-06 |
| DE68920610D1 (de) | 1995-03-02 |
| KR920000116B1 (ko) | 1992-01-09 |
| JPH02291277A (ja) | 1990-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68920610D1 (de) | Rekombinantes Virus der Marekschen Krankheit und Vakzin. | |
| ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
| DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
| ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
| DE3855947D1 (de) | Peptide mit den immunologischen Eigenschaften von HIV-2 | |
| LU91303I2 (fr) | Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP | |
| ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
| HUP9901035A2 (hu) | Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban | |
| BR0012433A (pt) | Vìrus recombinante, infeccioso de doença bursal infecciosa, método para obter o mesmo, ibdv mosaico infeccioso (mibdv), e, vacina | |
| DE60136278D1 (de) | Impfstoffe gegen viren der marek krankheit (mdv) und varicella zoster virus. | |
| DE69333057D1 (de) | Rekombinente Adenoviren-Impfstoffe | |
| ATE86119T1 (de) | Lebendvaccine fuer ansteckungskrankheiten von kueken. | |
| DE69818913D1 (de) | Rekombinanter Birnavirusimpfstoff | |
| EP0256677A3 (de) | Pseudorabiesvirus-Rekombinanten und ihre Verwendung zur Herstellung von Proteinen | |
| MX9102757A (es) | Vacuna de virus de enfermedad de marek sin celulas. | |
| WO1995005460A3 (en) | Feline immunodeficiency virus isolate ncsu 1 | |
| ATE103980T1 (de) | Das f-protein vom aids-virus enthaltender impfstoff. | |
| DE69203950D1 (de) | Rekombinanter Impfstoff gegen Marek's Krankheit. | |
| EA200100720A1 (ru) | Вирусная вакцина на основе делеционного вируса герпеса крупного рогатого скота типа 1 (bhv-1) | |
| Ishikawa et al. | Recombinant Marek's disease virus and vaccine | |
| DK204588D0 (da) | Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider | |
| DK257887A (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
| ES2105984A1 (es) | Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. | |
| DE69028658D1 (de) | Proteine, Vakzine und Nucleinsäuren | |
| ATE102252T1 (de) | Rekombinantes gefluegelpockenvirus, expressionsvektoren fuer heterologische proteine und davon derivierte gefluegelvakzine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |